Report Detail
Global First-in-Human (FIH) Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4718550 |
- 29 June, 2026 |
- Global |
- 135 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global First-in-Human (FIH) Services market size was valued at US$ 773 million in 2025 and is forecast to a readjusted size of US$ 1598 million by 2032 with a CAGR of 11.1% during review period.
First-in-Human Services refer to specialized services that support the planning, execution, and management of First-in-Human (FIH) clinical trials. These services are critical for the successful transition of a drug or therapeutic product from preclinical development to initial testing in human subjects. FIH trials are typically the first time a new drug is administered to humans, making the associated services essential for ensuring safety, compliance, and scientific validity.First-in-Human Services are essential for minimizing risks associated with the early testing of new drugs in humans, ensuring regulatory compliance, and generating reliable data that can influence subsequent phases of drug development. These services help streamline the clinical trial process, improve efficiency, and enhance the likelihood of successful product development.
This report is a detailed and comprehensive analysis for global First-in-Human (FIH) Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global First-in-Human (FIH) Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global First-in-Human (FIH) Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global First-in-Human (FIH) Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global First-in-Human (FIH) Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for First-in-Human (FIH) Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global First-in-Human (FIH) Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include WuXi AppTec, Allucent, Altasciences, LAXAI, Lonza, Syneos Health, CD BioSciences, Fortrea, Certara, Evotec, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
First-in-Human (FIH) Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Drugs
Medical Device
Market segment by Application
Pharmaceutical Companies
Contract Research Organizations (CROs)
Academic Institutions and Research Centers
Medical Device Companies
Market segment by players, this report covers
WuXi AppTec
Allucent
Altasciences
LAXAI
Lonza
Syneos Health
CD BioSciences
Fortrea
Certara
Evotec
Aixial Group
Quotient Sciences
Sofpromed
Spaulding Clinical
Biotrial
Crystal Pharmatech Co., Ltd
Avania
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe First-in-Human (FIH) Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of First-in-Human (FIH) Services, with revenue, gross margin, and global market share of First-in-Human (FIH) Services from 2021 to 2026.
Chapter 3, the First-in-Human (FIH) Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and First-in-Human (FIH) Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of First-in-Human (FIH) Services.
Chapter 13, to describe First-in-Human (FIH) Services research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of First-in-Human (FIH) Services by Type
- 1.3.1 Overview: Global First-in-Human (FIH) Services Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global First-in-Human (FIH) Services Consumption Value Market Share by Type in 2025
- 1.3.3 Drugs
- 1.3.4 Medical Device
- 1.4 Global First-in-Human (FIH) Services Market by Application
- 1.4.1 Overview: Global First-in-Human (FIH) Services Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Pharmaceutical Companies
- 1.4.3 Contract Research Organizations (CROs)
- 1.4.4 Academic Institutions and Research Centers
- 1.4.5 Medical Device Companies
- 1.5 Global First-in-Human (FIH) Services Market Size & Forecast
- 1.6 Global First-in-Human (FIH) Services Market Size and Forecast by Region
- 1.6.1 Global First-in-Human (FIH) Services Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global First-in-Human (FIH) Services Market Size by Region, (2021-2032)
- 1.6.3 North America First-in-Human (FIH) Services Market Size and Prospect (2021-2032)
- 1.6.4 Europe First-in-Human (FIH) Services Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific First-in-Human (FIH) Services Market Size and Prospect (2021-2032)
- 1.6.6 South America First-in-Human (FIH) Services Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa First-in-Human (FIH) Services Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 WuXi AppTec
- 2.1.1 WuXi AppTec Details
- 2.1.2 WuXi AppTec Major Business
- 2.1.3 WuXi AppTec First-in-Human (FIH) Services Product and Solutions
- 2.1.4 WuXi AppTec First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 WuXi AppTec Recent Developments and Future Plans
- 2.2 Allucent
- 2.2.1 Allucent Details
- 2.2.2 Allucent Major Business
- 2.2.3 Allucent First-in-Human (FIH) Services Product and Solutions
- 2.2.4 Allucent First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Allucent Recent Developments and Future Plans
- 2.3 Altasciences
- 2.3.1 Altasciences Details
- 2.3.2 Altasciences Major Business
- 2.3.3 Altasciences First-in-Human (FIH) Services Product and Solutions
- 2.3.4 Altasciences First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Altasciences Recent Developments and Future Plans
- 2.4 LAXAI
- 2.4.1 LAXAI Details
- 2.4.2 LAXAI Major Business
- 2.4.3 LAXAI First-in-Human (FIH) Services Product and Solutions
- 2.4.4 LAXAI First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 LAXAI Recent Developments and Future Plans
- 2.5 Lonza
- 2.5.1 Lonza Details
- 2.5.2 Lonza Major Business
- 2.5.3 Lonza First-in-Human (FIH) Services Product and Solutions
- 2.5.4 Lonza First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Lonza Recent Developments and Future Plans
- 2.6 Syneos Health
- 2.6.1 Syneos Health Details
- 2.6.2 Syneos Health Major Business
- 2.6.3 Syneos Health First-in-Human (FIH) Services Product and Solutions
- 2.6.4 Syneos Health First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Syneos Health Recent Developments and Future Plans
- 2.7 CD BioSciences
- 2.7.1 CD BioSciences Details
- 2.7.2 CD BioSciences Major Business
- 2.7.3 CD BioSciences First-in-Human (FIH) Services Product and Solutions
- 2.7.4 CD BioSciences First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 CD BioSciences Recent Developments and Future Plans
- 2.8 Fortrea
- 2.8.1 Fortrea Details
- 2.8.2 Fortrea Major Business
- 2.8.3 Fortrea First-in-Human (FIH) Services Product and Solutions
- 2.8.4 Fortrea First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Fortrea Recent Developments and Future Plans
- 2.9 Certara
- 2.9.1 Certara Details
- 2.9.2 Certara Major Business
- 2.9.3 Certara First-in-Human (FIH) Services Product and Solutions
- 2.9.4 Certara First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Certara Recent Developments and Future Plans
- 2.10 Evotec
- 2.10.1 Evotec Details
- 2.10.2 Evotec Major Business
- 2.10.3 Evotec First-in-Human (FIH) Services Product and Solutions
- 2.10.4 Evotec First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Evotec Recent Developments and Future Plans
- 2.11 Aixial Group
- 2.11.1 Aixial Group Details
- 2.11.2 Aixial Group Major Business
- 2.11.3 Aixial Group First-in-Human (FIH) Services Product and Solutions
- 2.11.4 Aixial Group First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Aixial Group Recent Developments and Future Plans
- 2.12 Quotient Sciences
- 2.12.1 Quotient Sciences Details
- 2.12.2 Quotient Sciences Major Business
- 2.12.3 Quotient Sciences First-in-Human (FIH) Services Product and Solutions
- 2.12.4 Quotient Sciences First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Quotient Sciences Recent Developments and Future Plans
- 2.13 Sofpromed
- 2.13.1 Sofpromed Details
- 2.13.2 Sofpromed Major Business
- 2.13.3 Sofpromed First-in-Human (FIH) Services Product and Solutions
- 2.13.4 Sofpromed First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Sofpromed Recent Developments and Future Plans
- 2.14 Spaulding Clinical
- 2.14.1 Spaulding Clinical Details
- 2.14.2 Spaulding Clinical Major Business
- 2.14.3 Spaulding Clinical First-in-Human (FIH) Services Product and Solutions
- 2.14.4 Spaulding Clinical First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Spaulding Clinical Recent Developments and Future Plans
- 2.15 Biotrial
- 2.15.1 Biotrial Details
- 2.15.2 Biotrial Major Business
- 2.15.3 Biotrial First-in-Human (FIH) Services Product and Solutions
- 2.15.4 Biotrial First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 Biotrial Recent Developments and Future Plans
- 2.16 Crystal Pharmatech Co., Ltd
- 2.16.1 Crystal Pharmatech Co., Ltd Details
- 2.16.2 Crystal Pharmatech Co., Ltd Major Business
- 2.16.3 Crystal Pharmatech Co., Ltd First-in-Human (FIH) Services Product and Solutions
- 2.16.4 Crystal Pharmatech Co., Ltd First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.16.5 Crystal Pharmatech Co., Ltd Recent Developments and Future Plans
- 2.17 Avania
- 2.17.1 Avania Details
- 2.17.2 Avania Major Business
- 2.17.3 Avania First-in-Human (FIH) Services Product and Solutions
- 2.17.4 Avania First-in-Human (FIH) Services Revenue, Gross Margin and Market Share (2021-2026)
- 2.17.5 Avania Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global First-in-Human (FIH) Services Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of First-in-Human (FIH) Services by Company Revenue
- 3.2.2 Top 3 First-in-Human (FIH) Services Players Market Share in 2025
- 3.2.3 Top 6 First-in-Human (FIH) Services Players Market Share in 2025
- 3.3 First-in-Human (FIH) Services Market: Overall Company Footprint Analysis
- 3.3.1 First-in-Human (FIH) Services Market: Region Footprint
- 3.3.2 First-in-Human (FIH) Services Market: Company Product Type Footprint
- 3.3.3 First-in-Human (FIH) Services Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global First-in-Human (FIH) Services Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global First-in-Human (FIH) Services Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global First-in-Human (FIH) Services Consumption Value Market Share by Application (2021-2026)
- 5.2 Global First-in-Human (FIH) Services Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America First-in-Human (FIH) Services Consumption Value by Type (2021-2032)
- 6.2 North America First-in-Human (FIH) Services Market Size by Application (2021-2032)
- 6.3 North America First-in-Human (FIH) Services Market Size by Country
- 6.3.1 North America First-in-Human (FIH) Services Consumption Value by Country (2021-2032)
- 6.3.2 United States First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 6.3.3 Canada First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 6.3.4 Mexico First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe First-in-Human (FIH) Services Consumption Value by Type (2021-2032)
- 7.2 Europe First-in-Human (FIH) Services Consumption Value by Application (2021-2032)
- 7.3 Europe First-in-Human (FIH) Services Market Size by Country
- 7.3.1 Europe First-in-Human (FIH) Services Consumption Value by Country (2021-2032)
- 7.3.2 Germany First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 7.3.3 France First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 7.3.5 Russia First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 7.3.6 Italy First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific First-in-Human (FIH) Services Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific First-in-Human (FIH) Services Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific First-in-Human (FIH) Services Market Size by Region
- 8.3.1 Asia-Pacific First-in-Human (FIH) Services Consumption Value by Region (2021-2032)
- 8.3.2 China First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 8.3.3 Japan First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 8.3.4 South Korea First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 8.3.5 India First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 8.3.7 Australia First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America First-in-Human (FIH) Services Consumption Value by Type (2021-2032)
- 9.2 South America First-in-Human (FIH) Services Consumption Value by Application (2021-2032)
- 9.3 South America First-in-Human (FIH) Services Market Size by Country
- 9.3.1 South America First-in-Human (FIH) Services Consumption Value by Country (2021-2032)
- 9.3.2 Brazil First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 9.3.3 Argentina First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa First-in-Human (FIH) Services Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa First-in-Human (FIH) Services Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa First-in-Human (FIH) Services Market Size by Country
- 10.3.1 Middle East & Africa First-in-Human (FIH) Services Consumption Value by Country (2021-2032)
- 10.3.2 Turkey First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
- 10.3.4 UAE First-in-Human (FIH) Services Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 First-in-Human (FIH) Services Market Drivers
- 11.2 First-in-Human (FIH) Services Market Restraints
- 11.3 First-in-Human (FIH) Services Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 First-in-Human (FIH) Services Industry Chain
- 12.2 First-in-Human (FIH) Services Upstream Analysis
- 12.3 First-in-Human (FIH) Services Midstream Analysis
- 12.4 First-in-Human (FIH) Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on First-in-Human (FIH) Services. Industry analysis & Market Report on First-in-Human (FIH) Services is a syndicated market report, published as Global First-in-Human (FIH) Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of First-in-Human (FIH) Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
